BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alldred MJ, Chao HM, Lee SH, Beilin J, Powers BE, Petkova E, Strupp BJ, Ginsberg SD. Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease. FASEB J 2019;33:9871-84. [PMID: 31180719 DOI: 10.1096/fj.201802669RR] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Powers BE, Velazquez R, Strawderman MS, Ginsberg SD, Mufson EJ, Strupp BJ. Maternal Choline Supplementation as a Potential Therapy for Down Syndrome: Assessment of Effects Throughout the Lifespan. Front Aging Neurosci 2021;13:723046. [PMID: 34690739 DOI: 10.3389/fnagi.2021.723046] [Reference Citation Analysis]
2 Alldred MJ, Lee SH, Stutzmann GE, Ginsberg SD. Oxidative Phosphorylation Is Dysregulated Within the Basocortical Circuit in a 6-month old Mouse Model of Down Syndrome and Alzheimer's Disease. Front Aging Neurosci 2021;13:707950. [PMID: 34489678 DOI: 10.3389/fnagi.2021.707950] [Reference Citation Analysis]
3 Martinez JL, Zammit MD, West NR, Christian BT, Bhattacharyya A. Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer's Disease. Front Aging Neurosci 2021;13:703876. [PMID: 34322015 DOI: 10.3389/fnagi.2021.703876] [Reference Citation Analysis]
4 Ghosh S, Durgvanshi S, Agarwal S, Raghunath M, Sinha JK. Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease. Curr Neuropharmacol 2020;18:883-903. [PMID: 32348223 DOI: 10.2174/1570159X18666200429011823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Alldred MJ, Lee SH, Ginsberg SD. Adiponectin Modulation by Genotype and Maternal Choline Supplementation in a Mouse Model of Down Syndrome and Alzheimer's Disease. J Clin Med 2021;10:2994. [PMID: 34279477 DOI: 10.3390/jcm10132994] [Reference Citation Analysis]
6 Lai SSM, Ng KY, Koh RY, Chok KC, Chye SM. Endosomal-lysosomal dysfunctions in Alzheimer's disease: Pathogenesis and therapeutic interventions. Metab Brain Dis 2021;36:1087-100. [PMID: 33881723 DOI: 10.1007/s11011-021-00737-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Stagni F, Uguagliati B, Emili M, Giacomini A, Bartesaghi R, Guidi S. The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome. Sci Rep 2021;11:6300. [PMID: 33737521 DOI: 10.1038/s41598-021-85284-5] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
8 D'Acunzo P, Pérez-González R, Kim Y, Hargash T, Miller C, Alldred MJ, Erdjument-Bromage H, Penikalapati SC, Pawlik M, Saito M, Saito M, Ginsberg SD, Neubert TA, Goulbourne CN, Levy E. Mitovesicles are a novel population of extracellular vesicles of mitochondrial origin altered in Down syndrome. Sci Adv 2021;7:eabe5085. [PMID: 33579698 DOI: 10.1126/sciadv.abe5085] [Cited by in Crossref: 11] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
9 Lanzillotta C, Di Domenico F. Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules. Biomolecules 2021;11:266. [PMID: 33670211 DOI: 10.3390/biom11020266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Derbyshire E, Obeid R. Choline, Neurological Development and Brain Function: A Systematic Review Focusing on the First 1000 Days. Nutrients 2020;12:E1731. [PMID: 32531929 DOI: 10.3390/nu12061731] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]